A mutual recognition agreement (MRA) between the Swiss and US regulatory agencies on good manufacturing practice (GMP) inspections of drug companies signed earlier this year has come into effect, paving the way for reduced administrative and financial burden on both industry and regulatory authorities in the two regions.
Switzerland, US Agreement On GMP Inspections Comes Into Play
An agreement between Switzerland and the US means that the competent authority of the importing country can now rely on the manufacturing inspections of the partner authority.
